Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04597502 · ClinicalTrials.gov registry record · NA

The Effects of Terminalia Chebula Fruit Extract on the Gut Microbiome and Skin Biophysical Properties

A NA study of Human Microbiome, sponsored by Integrative Skin Science and Research.

Completed
Registry status
NA
Development phase
58
Enrollment target
1
Study location

NCT04597502 is a NA study of Human Microbiome that has completed, run by Integrative Skin Science and Research. The registered enrollment target is 58 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04597502, a NA study of Human Microbiome, has completed, sponsored by Integrative Skin Science and Research.

COMPLETED
Registry status
NA
Development phase
58 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess the use of oral Terminalia chebula fruit extract on the gut microbiome and skin biophysical properties. The fruit is commonly used for skin treatments in India. It is thought to have antioxidant properties, reduce inflammation and affect the microorganisms in the gut. The information the investigators will learn from this study may indicate how and if oral dosing can affect the skin and gut microbiome. This may lead to an improved understanding of the skin and determine whether these oral products are effective for improving the skin's appearance.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Terminalia Chebula fruit extract
  • OTHER Topical Terminalia Chebula
  • OTHER Topical Placebo

Study Locations (1)

California

  • Integrative Skin Science and Research - Sacramento

Trial Details

FieldValue
Enrollment Target 58 participants
Start Date 2020-10-15
Est. Completion 2022-09-01
Phase NA

What the Registry Record Tells You About NCT04597502

The ClinicalTrials.gov registry entry for NCT04597502 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Integrative Skin Science and Research, which has 15 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Human Microbiome appearing as the primary indexed condition, and to 4 interventions - of which Placebo is the first listed.

NCT04597502 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04597502 about?

NCT04597502 is a clinical study titled "The Effects of Terminalia Chebula Fruit Extract on the Gut Microbiome and Skin Biophysical Properties". The purpose of this study is to assess the use of oral Terminalia chebula fruit extract on the gut microbiome and skin biophysical properties. The fruit is commonly used for skin treatments in India. It is thought to have antioxidant properties, reduce inflammation and affect the microorganisms in t...

What is the current status of trial NCT04597502?

This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2020-10-15. Estimated completion is 2022-09-01.

What conditions does trial NCT04597502 study?

This clinical trial studies the following conditions: Human Microbiome.

What interventions are being tested in trial NCT04597502?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Terminalia Chebula fruit extract (DIETARY_SUPPLEMENT), Topical Terminalia Chebula (OTHER), Topical Placebo (OTHER).

Who is sponsoring clinical trial NCT04597502?

This trial is sponsored by Integrative Skin Science and Research, which has 15 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04597502 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Human Microbiome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.